Walter Z Wang (Walter Wang)

Years Active: 2018-2021
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Walter Z Wang, Konstantin Shilo, Joseph M Amann, Alyssa Shulman, Mohammad Hojjat-Farsangi, Håkan Mellstedt, Johan Schultz, Carlo M Croce, David P Carbone
Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung. Cell death & disease 12 (6) (2021)
Michael J Koenig, Bernice A Agana, Jacob M Kaufman, Michael F Sharpnack, Walter Z Wang, Christoph Weigel, Fábio C P Navarro, Joseph M Amann, Nicole Cacciato, Rajeswara Rao Arasada, Mark B Gerstein, Vicki H Wysocki, Christopher Oakes, David P Carbone
STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and S-Adenosyl-Methionine Depletion in Human Lung Adenocarcinoma. Cancer research 81 (16) (2021)
Walter Z Wang, David P Carbone, Rajeswara Rao Arasada
Novel mechanism of resistance to targeted therapies in lung cancer. Molecular & cellular oncology 6 (1) (2018)
Rajeswara Rao Arasada, Konstantin Shilo, Tadaaki Yamada, Jianying Zhang, Seiji Yano, Rashelle Ghanem, Walter Z Wang, Shinji Takeuchi, Koji Fukuda, Nobuyuki Katakami, Keisuke Tomii, Fumitaka Ogushi, Yasuhiko Nishioka, Tiffany Talabere, Shrilekha Misra, Wenrui Duan, Paolo Fadda, Mohammad A Rahman, Patrick Nana-Sinkam, Jason Evans, Joseph Amann, Elena E Tchekneva, Mikhail M Dikov, David P Carbone
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC. Nature communications 9 (1) (2018)

Walter Z Wang.css-eqlu8i{font-size:small;padding-left:4px;} (Walter Wang)